• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Practical Matters: Artificial tears are vital in treating dry eye

March 1, 2005
J. Daniel Brogdon, DVM, MS, DACVO

Keratoconjunctivitis sicca (KCS), or dry eye, is a painful condition in which tear production is decreased or absent and the cornea becomes dry and irritated. If the condition is left untreated, loss of vision can result.

Keratoconjunctivitis sicca (KCS), or dry eye, is a painful condition in which tear production is decreased or absent and the cornea becomes dry and irritated. If the condition is left untreated, loss of vision can result. Cyclosporine and tacrolimus ophthalmic preparations are commonly used to increase tear production. Typically, dry eye patients are treated for life with cyclosporine or tacrolimus, frequent artificial tears, and perhaps initially with a topical antibiotic or anti-inflammatory until the tear production returns to normal. Frequent applications of artificial tear lubricants are vital to successful treatment of KCS. It is important to remember that KCS can result from a deficiency in not only the aqueous layer of the tear film but the mucous or lipid layer as well.

J. Daniel Brogdon, DVM, MS DACVO

Advertisement

Jacksonville Animal Eye Clinic

3444 Southside Blvd., Suite 104

Jacksonville, FL 32216

Related Content:

Ophthalmology
Bausch + Lomb debuts Project Watson health care products for dogs
Bausch + Lomb debuts Project Watson health care products for dogs
Sentrx Animal Care teams up with Provet
Sentrx Animal Care teams up with Provet
Get back to school with dvm360 Flex™ continuing education
Get back to school with dvm360 Flex™ continuing education

Advertisement

Latest News

What's new with the "Dentistry Lane" across the veterinary profession?

Meet the BlackDVM Network

Study finds certain canine breeds should be screened for cancer at young ages

AVMA releases 2 videos informing pet parents on pet dental care

View More Latest News
Advertisement